Florida medical practices do not get to choose between FIPA and HIPAA. Depending on the organization, the information involved, and what happened to that information, both laws may apply at the same time.
That distinction matters whenever a practice collects patient details through a website, stores leads in a CRM, installs Google Analytics 4 or Meta Pixel, publishes before-and-after photographs, or sends conversion events to an advertising platform.
FIPA vs HIPAA in one sentence: HIPAA regulates how covered entities and business associates use and protect protected health information, while FIPA requires a broader group of businesses to secure specified personal information and respond to breaches involving people in Florida.
In our work with Florida medical practices, we do not begin by asking whether a particular plugin is “HIPAA compliant.” We begin by tracing the data: what is collected, whether it can identify a person, what it reveals about that person, where it is transmitted, which vendors receive it, and what agreements authorize those disclosures.
That is the only reliable way to understand whether FIPA, HIPAA, both laws, or another privacy framework applies.
This guide focuses on the Florida layer. For the wider federal framework, enforcement environment, and security requirements, start with our complete guide to HIPAA compliance in 2026.
This article provides general educational information and is not legal advice. A healthcare attorney should evaluate your practice’s specific facts, contracts, authorizations, and breach obligations.
The Florida Information Protection Act of 2014, commonly called FIPA, is codified in Florida Statutes §501.171. It requires covered commercial entities, governmental entities, and third-party agents to take reasonable measures to secure certain personal information stored electronically.
HIPAA is a federal framework. Its Privacy, Security, and Breach Notification Rules apply principally to covered healthcare providers, health plans, healthcare clearinghouses, and their business associates.
The practical difference is scope.
A company can be subject to FIPA even when it is not a HIPAA covered entity or business associate. A marketing company, software vendor, call center, form processor, or general business may fall within FIPA if it acquires, maintains, stores, or uses protected personal information.
Conversely, not every piece of information protected by HIPAA will trigger FIPA in precisely the same way. Each statute has its own definitions, exceptions, enforcement structure, and notification requirements.
When both laws are triggered, a Florida practice must satisfy both. HIPAA does not erase state obligations merely because the incident involves healthcare data. In operational terms, the practice should build its response around the requirement that is broader, faster, or more protective for the situation in question.
For example, HIPAA generally sets an outside limit of 60 days for individual breach notification, while FIPA generally requires notice to affected individuals no later than 30 days after determining that a covered breach occurred, subject to specified exceptions and authorized delays. FIPA also requires a third-party agent to notify the covered entity as soon as practicable and no later than 10 days after determining or having reason to believe that a breach occurred.
We therefore treat HIPAA and FIPA as overlapping controls, not interchangeable laws. A compliance program built only around HIPAA’s terminology can overlook credentials, financial information, geolocation, vendor deadlines, and other elements expressly addressed by Florida law.
FIPA is primarily a data-security and breach-response law. It is not simply “Florida HIPAA,” and it is not limited to hospitals, physicians, insurers, or other healthcare organizations.
Under the statute, a FIPA covered entity includes a sole proprietorship, partnership, corporation, trust, association, or other commercial entity that acquires, maintains, stores, or uses personal information. Governmental entities are also included for the relevant notice provisions.
The definition is important for medical practices because a patient-data workflow rarely stays inside the practice.
A typical lead or patient journey can involve:
Under FIPA, a contracted entity that maintains, stores, or processes personal information on behalf of a covered entity can qualify as a third-party agent. That creates a direct operational reason to review vendor contracts, incident-notification clauses, access controls, retention periods, and deletion procedures.
In our audits, we regularly see practices concentrate almost entirely on the EHR while overlooking the systems that receive information before someone becomes a patient. A consultation form, chat transcript, call recording, financing inquiry, or CRM record may contain enough information to trigger serious privacy and security obligations.
FIPA requires covered entities and third-party agents to use reasonable measures to protect electronic personal information. It also requires reasonable disposal measures when customer records no longer need to be retained. Those requirements include making the information unreadable or undecipherable rather than merely moving it to a trash folder.
FIPA’s definition can include a person’s name combined with information such as:
The statute also covers a username or email address combined with a password or security answer that permits access to an online account.
This breadth is one reason a Florida medical practice cannot limit its audit to clinical notes. Billing information, portal credentials, financing data, location data, and account-access information may create a FIPA issue even when the HIPAA analysis is more complicated.
HIPAA is narrower in who it regulates but more detailed in how regulated entities must handle protected health information.
The federal rules apply to covered entities and business associates. A covered healthcare provider generally falls within HIPAA when it conducts specified electronic healthcare transactions. A business associate is a person or organization performing certain functions or services involving PHI on behalf of a covered entity.
A vendor does not become safe merely because it calls itself “HIPAA ready.” The relevant questions are whether the vendor creates, receives, maintains, or transmits PHI; whether the proposed use or disclosure is permitted; whether a business associate relationship exists; and whether an adequate BAA has been executed.
HHS explains that covered entities using business associates must establish written contractual protections for PHI. Those contracts should define permitted uses, safeguards, reporting responsibilities, subcontractor obligations, termination procedures, and other required terms. HHS’s business-associate guidance provides the federal foundation for that analysis.
PHI is not limited to diagnoses or medical records. It can include individually identifiable information concerning a person’s health, care, or payment for care when maintained or transmitted by a HIPAA-regulated entity.
That distinction is crucial for websites. Information entered into an appointment form can reveal both identity and an intention to receive a particular healthcare service. A portal login may expose identifiers, appointment dates, prescriptions, bills, or treatment information. A symptom checker can combine an email address with health details before the person has ever visited the office.
HHS’s current tracking guidance states that tracking technologies on authenticated pages generally have access to PHI. It also explains that unauthenticated pages may involve PHI when a visitor schedules care, submits symptoms, enters identifying information, or otherwise reveals information connected to past, present, or future healthcare.
At the same time, HHS recognizes that a visit to a general public page does not automatically become PHI solely because an IP address and a healthcare-related URL are involved. The facts and the relationship between the information matter. That nuance is why blanket statements such as “every pixel on every medical website is automatically illegal” are not reliable.
HHS proposed significant updates to the HIPAA Security Rule in December 2024. Those proposals include more prescriptive cybersecurity requirements, but the official HHS page still classifies the measure as a proposed rule and states that the existing Security Rule remains in effect while rulemaking continues.
A Florida practice should prepare for stronger controls without presenting proposed requirements as already-final law. Risk analysis, access control, vendor management, incident response, encryption decisions, and documentation are important now—not only after a future final rule.
A 60-day HIPAA deadline is not permission to wait 60 days. HIPAA requires notification without unreasonable delay and places 60 days as the outside limit.
FIPA likewise requires action as quickly as practicable, but its outside deadline is generally 30 days for affected individuals. The Florida Department of Legal Affairs must also be notified within 30 days when 500 or more individuals in Florida are affected.
For third-party incidents, the difference is even more significant. HIPAA gives a business associate an outside limit of 60 days to notify the covered entity. FIPA sets a 10-day outside limit for a third-party agent.
That is why vendor contracts for Florida practices should not stop at generic HIPAA language. A BAA that permits notification near the end of HIPAA’s 60-day period can leave the practice unable to satisfy FIPA’s 30-day obligation.
We recommend writing the shorter Florida escalation requirement into relevant vendor contracts. The contract should also require immediate preservation of evidence, a preliminary affected-data assessment, identification of Florida residents, cooperation with forensic review, and delivery of the information the practice needs to make notification decisions.
FIPA also requires notification to nationwide consumer-reporting agencies when more than 1,000 individuals must be notified at one time.
FIPA permits civil penalties of up to $500,000 for specified failures to provide required notices. The statute describes daily and 30-day-period calculations and clarifies that the notification penalties apply per breach rather than per affected person. It also treats violations as unfair or deceptive trade practices in actions brought by the Florida Department of Legal Affairs.
Although FIPA itself creates no private cause of action, a data incident may still generate litigation under negligence, contract, confidentiality, consumer-protection, or other legal theories. The distinction should be preserved in every article, risk report, and sales presentation.
HIPAA penalties operate under a separate federal structure and are periodically adjusted. Rather than hard-coding an old maximum into this article, practices should verify current penalty amounts through HHS and the Federal Register when evaluating a specific incident.
A medical practice’s marketing stack is part of its data environment. The website, analytics tools, ad pixels, CRM, call tracking, chat, scheduling, and automation systems should be included in the same risk analysis as other systems that may create, receive, maintain, or transmit protected information.
For a broader vertical-specific application, see our guide to HIPAA-compliant marketing for plastic surgery clinics.
Google states that HIPAA-regulated entities must not expose PHI to Google Analytics, that Google does not represent Google Analytics as satisfying HIPAA requirements, and that it does not offer a BAA for the service. Google’s HIPAA and Google Analytics guidance is unusually direct on this point.
That does not mean the name “GA4” automatically determines the legal result. The implementation does.
A practice should determine whether GA4 receives:
Sending PHI to a vendor that will not execute a BAA cannot be fixed by adding another paragraph to the privacy policy. It requires changing the data flow.
Our separate guide examines whether Google Analytics 4 is HIPAA compliant and how to evaluate individual events, parameters, pages, and integrations without turning this comparison page into a duplicate GA4 article.
Google states that HIPAA-regulated entities must not expose PHI to Google Analytics, that Google does not represent Google Analytics as satisfying HIPAA requirements, and that it does not offer a BAA for the service. Google’s HIPAA and Google Analytics guidance is unusually direct on this point.
That does not mean the name “GA4” automatically determines the legal result. The implementation does.
A practice should determine whether GA4 receives:
Sending PHI to a vendor that will not execute a BAA cannot be fixed by adding another paragraph to the privacy policy. It requires changing the data flow.
Our separate guide examines whether Google Analytics 4 is HIPAA compliant and how to evaluate individual events, parameters, pages, and integrations without turning this comparison page into a duplicate GA4 article.
Meta Pixel creates a similar risk category. The central question is not whether the pixel appears in the source code. The question is what information the implementation makes available to Meta.
A standard marketing setup may communicate page visits, events, browser identifiers, campaign parameters, or conversion details. On a medical website, those signals can become sensitive when combined with an identifiable person’s appointment request, treatment interest, symptom information, or portal activity.
HHS requires regulated entities to determine whether tracking vendors are receiving PHI and, when the business-associate rules apply, to ensure the disclosure is permitted and a BAA is in place. If a vendor will not provide the required assurances, the practice should not send PHI to that vendor without a valid alternative legal basis.
This analysis should cover browser-side Pixel code, Conversions API, CRM audience uploads, offline event imports, custom audiences, and lead-ad integrations. Moving the same prohibited payload from a browser to a server does not change the nature of the disclosure.
Server-side tracking can provide better control, but it is not a compliance certificate.
A well-designed server-side architecture can:
HHS’s tracking guidance specifically describes the possibility of using a customer data platform willing to act as a business associate, de-identify information containing PHI, and disclose only properly de-identified information to another tracking vendor.
That approach requires more than hashing an email address. Hashing is typically pseudonymization, not automatic HIPAA de-identification. The resulting value can still function as an identifier or be matched against other datasets.
When we design server-side measurement, our first rule is that the server cannot become a hidden relay for the same information we removed from the browser. Every outgoing field must have a documented purpose, destination, retention rule, and authorization.
Our implementation-focused article on server-side tracking for medical practices should own the detailed technical discussion: event allowlists, transformation layers, consent states, cloud configuration, logging, offline conversion workflows, testing, and rollback controls.
A CRM can be configured securely and still be the wrong vendor for a particular workflow. A vendor may offer a BAA only on certain plans, products, accounts, or configurations. Some integrations may fall outside the covered service.
For each CRM or form platform, verify:
We do not accept a vendor’s “HIPAA-ready” badge as a substitute for a signed agreement and tested configuration. The contract, actual data flow, user permissions, integration settings, and operating procedures must tell the same story.
A BAA, a privacy policy, a cookie banner, and a patient authorization perform different functions. Treating them as interchangeable creates unnecessary risk.
A BAA governs a qualifying relationship between a regulated entity and a business associate. It does not authorize every possible use of PHI, and signing one does not automatically make every integration compliant.
A privacy policy tells visitors about data practices. It does not, by itself, create permission under HIPAA to disclose PHI to a tracking vendor.
A cookie banner can manage tracking preferences under various privacy frameworks, but HHS states that an accept-or-reject banner does not constitute a valid HIPAA authorization. HHS also explains that describing tracking in a privacy policy or terms of use does not, by itself, permit a PHI disclosure.
A HIPAA authorization must satisfy specific regulatory requirements. For marketing uses and disclosures of PHI, HIPAA generally requires individual authorization subject to limited exceptions. HHS’s marketing guidance explains this distinction.
This is especially relevant to before-and-after photographs, testimonials, reviews, videos, and social-media content.
A photograph can reveal identity, treatment, physical condition, provider relationship, or procedure outcome. Even when a face is cropped, tattoos, scars, jewelry, backgrounds, dates, file names, and metadata can make a person identifiable.
A defensible workflow should include:
FIPA is not a general replacement for this HIPAA authorization analysis. FIPA focuses heavily on securing specified personal information, handling third parties, disposing of records, and responding to breaches. The HIPAA Privacy Rule addresses whether a regulated entity may use or disclose PHI for marketing.
A compliance review should test what the website does, not merely compare the privacy policy with a template.
During website audits, we review what actually leaves the browser, what reaches the server, and what is forwarded from the server to other vendors.
Inventory every data-collection surface
Contact forms · Appointment forms · Patient-portal login and registration pages · Symptom checkers · Chat and chatbot tools · Call-tracking numbers · Financing applications · Newsletter forms · Career forms · Download gates · Review widgets · Embedded maps and videos · Before-and-after galleries
Inventory every recipient
Analytics platforms · Advertising networks · Tag managers · CRM systems · Form processors · Scheduling tools · Email and SMS providers · Cloud hosts · Call-recording vendors · CDPs and data warehouses · Agencies and contractors
Capture the actual payloads
Test network requests, server logs, webhooks, API calls, URL parameters, browser storage, cookies, event objects, form submissions, CRM syncs, and offline conversion exports · Do not assume a field is safe because its label sounds generic: an event called generate_lead can still carry a treatment name, appointment type, email, click ID, IP address, or CRM identifier
Classify the information
PHI or ePHI under HIPAA · Personal information under FIPA · A direct identifier · A persistent or linkable identifier · Properly de-identified information · Data unnecessary for the stated purpose
Verify agreements and permissions
Whether a BAA is required · Whether one has been signed · Which product and account it covers · Whether subcontractors are addressed · The incident-notification deadline · Data-return and destruction obligations · Audit or cooperation rights · Whether the proposed use is actually permitted
Test high-risk pages separately
Authenticated pages, portal registration, appointment scheduling, symptom tools, consultation forms, payment pages, and treatment-specific landing pages deserve individual testing — a global tag can behave differently by template, consent state, campaign parameters, or logged-in status
Review patient media
Match every photograph, testimonial, or video with its authorization, and confirm the approved use covers the current channel and campaign
Document remediation
The affected page or system · The data involved · The receiving vendor · The applicable legal issue · Severity · Temporary containment · Permanent remediation · Owner · Deadline · Validation evidence
A one-time scan is useful, but configuration drift can reintroduce risk. New plugins, landing pages, ad campaigns, staff accounts, CRM workflows, and vendor updates should trigger repeat testing.
To identify exposed trackers, forms, and vendor connections before choosing a remediation plan, run a HIPAA website exposure scan with HIPAAdvisor.
A suspected disclosure should trigger a coordinated factual and legal investigation. It should not trigger an immediate public conclusion that a reportable breach definitely occurred.
The first steps are to contain the data flow, preserve evidence, identify affected systems, involve privacy and security leadership, notify legal counsel, and obtain information from relevant vendors.
For Florida organizations, the response calendar needs to account for both frameworks:
| Notification trigger | Deadline |
|---|---|
| FIPA third-party agent → covered entity | No more than 10 days after determining, or having reason to believe, a breach occurred |
| FIPA notice to affected individuals | As soon as practicable; generally no later than 30 days |
| Florida Department of Legal Affairs | Within 30 days when 500 or more individuals in Florida are affected |
| Nationwide consumer-reporting agencies | When more than 1,000 people require notice at one time |
| HIPAA notice to affected individuals | Without unreasonable delay; no later than 60 days |
| HIPAA notice to HHS and the media | Varies according to the size and geographic impact of the breach |
The practice should also determine whether the information was secured, whether an impermissible use or disclosure occurred, whether a HIPAA risk assessment demonstrates a low probability of compromise, and whether a FIPA exception or documented no-harm determination applies.
FIPA requires specified no-harm determinations to be documented and retained for at least five years. HIPAA also places the burden on regulated entities to document that required notices were provided or that notification was not required.
The incident plan should therefore include parallel workstreams for legal analysis, forensics, vendor cooperation, patient communication, regulator notice, remediation, and evidence retention.
The goal is not to eliminate measurement. The goal is to measure without sending data to organizations that should not receive it.
A defensible architecture usually includes:
This approach also supports SEO, AEO, and GEO. A compliant website does not need to sacrifice discoverability. It needs a cleaner relationship between content, conversion, measurement, and patient data.
The pillar-and-cluster architecture used here reinforces that separation. The pillar explains the wider HIPAA environment. This page addresses the Florida state-versus-federal comparison. The GA4 and server-side pages answer product and implementation questions. The plastic-surgery page applies the framework to a specific medical vertical.
That produces a cleaner topical graph for search engines and answer engines while reducing the risk that four pages compete for the same query.
The same principle applies technically: each system should have a defined purpose. A CRM should manage approved relationships. An analytics system should receive only approved measurement data. An ad platform should receive only information that the practice is permitted to disclose. A server should enforce those rules rather than obscure violations.
No. FIPA and HIPAA are separate laws. A Florida medical practice may have to comply with both when an incident involves PHI and personal information protected under Florida law.
Not in every respect. FIPA reaches a broader range of businesses and certain categories of personal information, and its breach-notification deadlines can be shorter. HIPAA contains more detailed privacy, security, authorization, and business-associate requirements. The practice must analyze both.
It can. FIPA’s commercial-entity definition is not limited to large companies. The relevant issues include whether the practice acquires, maintains, stores, or uses the personal information defined by the statute.
Affected individuals generally must be notified as soon as practicable and no later than 30 days after the covered entity determines or has reason to believe that a breach occurred, subject to statutory exceptions and delays. The Florida Department of Legal Affairs must be notified within 30 days when 500 or more individuals in Florida are affected.
A qualifying third-party agent must notify the covered entity as soon as practicable and no later than 10 days after determining that a breach occurred or having reason to believe it occurred.
Google does not represent Google Analytics as satisfying HIPAA requirements and does not offer a BAA for Google Analytics. A HIPAA-regulated entity must prevent PHI from being disclosed to GA4. Whether a particular implementation creates a problem depends on the data transmitted and the context.
No. Server-side tracking can improve control and support de-identification, but it can also forward the same sensitive data through a different route. Compliance depends on payloads, permissions, vendors, BAAs, security controls, and the resulting disclosures.
No. HHS states that a conventional accept-or-reject cookie banner is not a valid HIPAA authorization. A privacy policy disclosure is also not sufficient by itself to authorize disclosure of PHI to a tracking vendor.
Identifiable patient photos used for marketing generally require an appropriate HIPAA authorization when the practice is a regulated entity and the images constitute PHI. The authorization should specifically cover the intended media, channels, and uses.
FIPA and HIPAA protect overlapping information through different legal structures. HIPAA focuses on regulated healthcare relationships and PHI. FIPA protects defined categories of personal information held by a much broader range of Florida businesses and imposes shorter deadlines in important breach scenarios.
For Florida practices, the most effective strategy is not to maintain two disconnected compliance programs. It is to create one data-governance system that can identify which rules apply to each workflow, vendor, disclosure, and incident.
Start with the data flow. Verify every BAA. Test every form and tracker. Separate patient systems from advertising systems. Treat server-side tracking as a control layer, not a loophole. Use specific patient authorizations for marketing content. Build FIPA’s 10-day vendor notice into contracts. And document what your website actually transmits.
That is how a practice can protect patients, preserve useful measurement, and grow without allowing its marketing stack to become its largest compliance blind spot.
Call Growth Marketing Studios today or book a 20-minute assessment. We will map your marketing data flow, flag HIPAA exposure in your forms, tracking, and CRM, and show you how to scale patient acquisition without putting patient data at risk.
Tell us where your practice is today, and where you want it to be. We’ll build a revenue plan that cuts spam by up to 92%, sends only pre-qualified prospects to your coordinators (often lifting monthly sales by up to 76%), keeps deposit patients engaged for 12 months (driving ~75% more long-tail closes), and brings more post-op patients back (~22% repeat procedures). Our team deploys compliant automation across Aesthetix CRM, GoHighLevel, or your existing Medical CRM for Doctors, Surgeons & Healthcare, without adding busywork. Share a few details and we’ll show exactly which leaks to fix first and how this can pay for itself in a quarter.
Message us
support@growthmarketingstudios.com